Alexandria Real Estate Equities

ARE-N

NYSE:ARE

151.13
3.59 (2.32%)
Alexandria Real Estate Equities is a major United States real estate investment trust.
More at Wikipedia

Analysis and Opinions about ARE-N

Signal
Opinion
Expert
PAST TOP PICK
PAST TOP PICK
December 2, 2019
(A Top Pick Dec 05/18, Up 33%) When he called it, ARE wasn't cheap. They hold life sciences properties, which is solid and lucrative (fuelled by R&D spending). They can raise rents by 20-30% annually with these companies, which means strong cash flow growth.
Show full opinionHide full opinion
(A Top Pick Dec 05/18, Up 33%) When he called it, ARE wasn't cheap. They hold life sciences properties, which is solid and lucrative (fuelled by R&D spending). They can raise rents by 20-30% annually with these companies, which means strong cash flow growth.
PAST TOP PICK
PAST TOP PICK
October 9, 2019
(A Top Pick Aug 16/18, Up 24%) One of the best capital compounders out there. They build life sciences buildings on campuses across the US. Biotech companies co-locate on these campuses, creating great opportunities. The fundamentals remain positive and he continues to hold it.
Show full opinionHide full opinion
(A Top Pick Aug 16/18, Up 24%) One of the best capital compounders out there. They build life sciences buildings on campuses across the US. Biotech companies co-locate on these campuses, creating great opportunities. The fundamentals remain positive and he continues to hold it.
PAST TOP PICK
PAST TOP PICK
April 1, 2019
(A Top Pick Dec 05/18, Up 16%) They are a stellar company with a stellar management team. They are the dominant player of campuses to life sciences companies. It is important for these companies to be together to share ideas in an ecosystem. They have a free cash flow growth of north of 10%. He sees the company growing with their valuation. It is still a compelling investment opportunity.
Show full opinionHide full opinion
(A Top Pick Dec 05/18, Up 16%) They are a stellar company with a stellar management team. They are the dominant player of campuses to life sciences companies. It is important for these companies to be together to share ideas in an ecosystem. They have a free cash flow growth of north of 10%. He sees the company growing with their valuation. It is still a compelling investment opportunity.
TOP PICK
TOP PICK
December 5, 2018
The entry point is great right now. They look to double their revenues by 2022 from $900 million today. They have a great balance sheet and management team. They hold assets in all the major US campuses. They are the curators of new biotech and big pharma real estate start-ups on and near these campuses. When a lease comes due, they can raise rents 30% or more. Yield 3%. (Analysts’ price target is $138.25)
Show full opinionHide full opinion
The entry point is great right now. They look to double their revenues by 2022 from $900 million today. They have a great balance sheet and management team. They hold assets in all the major US campuses. They are the curators of new biotech and big pharma real estate start-ups on and near these campuses. When a lease comes due, they can raise rents 30% or more. Yield 3%. (Analysts’ price target is $138.25)
PAST TOP PICK
PAST TOP PICK
December 5, 2018
(A Top Pick Aug 16/18, Down 3%) They hold assets in all the major US campuses. They are the curators of new biotech and big pharma real estate start-ups on and near these campuses. When a lease comes due, they can raise rents 30% or more.
Show full opinionHide full opinion
(A Top Pick Aug 16/18, Down 3%) They hold assets in all the major US campuses. They are the curators of new biotech and big pharma real estate start-ups on and near these campuses. When a lease comes due, they can raise rents 30% or more.
TOP PICK
TOP PICK
August 16, 2018

They specialize in technology and life-sciences clusters. Their tenants will be repatriation cash, so ARE's partnership with these tenants will create value and rent growth. (2.9% dividend yield)

Show full opinionHide full opinion

They specialize in technology and life-sciences clusters. Their tenants will be repatriation cash, so ARE's partnership with these tenants will create value and rent growth. (2.9% dividend yield)

Showing 1 to 6 of 6 entries
  • «
  • 1
  • »

Alexandria Real Estate Equities(ARE-N) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 2

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 2

Stockchase rating for Alexandria Real Estate Equities is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Alexandria Real Estate Equities(ARE-N) Frequently Asked Questions

What is Alexandria Real Estate Equities stock symbol?

Alexandria Real Estate Equities is a American stock, trading under the symbol ARE-N on the New York Stock Exchange (ARE). It is usually referred to as NYSE:ARE or ARE-N

Is Alexandria Real Estate Equities a buy or a sell?

In the last year, 2 stock analyst published opinions about ARE-N. 2 analyst recommended to BUY the stock. 0 analyst recommended to SELL the stock. The latest stock analyst recommendation is PAST TOP PICK. Read the latest stock experts' ratings for Alexandria Real Estate Equities.

Is Alexandria Real Estate Equities a good investment or a top pick?

Alexandria Real Estate Equities was recommended as a Top Pick by Joshua Varghese on 2019-12-02. Read the latest stock experts ratings for Alexandria Real Estate Equities.

Why is Alexandria Real Estate Equities stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Alexandria Real Estate Equities worth watching?

2 stock analyst on Stockchase covered Alexandria Real Estate Equities In the last year. It is a trending stock that is worth watching.

What is Alexandria Real Estate Equities stock price?

On 2020-06-04, Alexandria Real Estate Equities (ARE-N) stock closed at a price of $151.13.